Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China State Council Solicits Public Opinion Again For Healthcare Reform Plan

This article was originally published in PharmAsia News

Executive Summary

China's State Council has decided to solicit public opinion again to deepen its health care reform proposal. The draft spells out the reform's direction, objective, principles and key measures, with the overall goal of building up the basic healthcare system to cover both urban and rural residents by 2020. In the near term, the government will focus on five areas: (1) speeding up the guaranteed coverage of healthcare; (2) building a national basic medicine system; (3) completing health care service system at the primary level; (4) promoting uniform basic healthcare service; and (5) pushing reform pilots in public hospitals. A reform participant discloses that the proposal comprises a health reform framework and a complementary set of documents, with the latter detailing specific measures for implementation. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel